Search results
Novo Nordisk: Growth Is Still A Better Choice
GuruFocus.com via Yahoo Finance· 3 days agoNovo Nordisk A/S (NYSE:NVO) is the largest Danish pharmaceutical company focusing on developing medicines to combat obesity, diabetes, cardiovascular...
Novo Nordisk to begin 2024 share buybacks
Reuters via Yahoo Finance· 3 months agoOSLO (Reuters) - Novo Nordisk will on Tuesday begin the execution of its planned share buyback programme for 2024, the Danish maker of obesity drug...
Why Novo Nordisk Topped the Market Today
Motley Fool via Yahoo Finance· 1 week agoHardly for the first time in recent weeks and months, Novo Nordisk (NYSE: NVO) had a good trading session on the stock market Monday. The company's...
Novo Nordisk Q4 Highlights: Clocks 25% Increase In Sales On Strong Diabetes and Obesity Treatment,...
Benzinga via Yahoo Finance· 1 year agoNovo Nordisk A/S (NYSE: NVO) reported Q4 FY22 sales of DKK 48.09 billion, up 25% Y/Y (+18% on...
Why Novo Nordisk Stock Bumped Higher Today
Motley Fool· 11 months agoNovo Nordisk (NYSE: NVO) had yet another good session on the stock market Tuesday. The company said it has accumulated just under 1.25 million shares of...
Top Analyst Reports for Microsoft, Novo Nordisk & United Parcel
Zacks via Yahoo Finance· 2 weeks agoToday's Research Daily features new research reports on 16 major stocks, including Microsoft...
Why Novo Nordisk Stock Thrashed the Market on Monday
Motley Fool· 9 months agoThe broader stock market might have been a bit sluggish in the summer heat on Monday, but investors didn't hesitate to pile into Novo Nordisk (NYSE:...
Novo Nordisk launches 'strong' guidance, warns of supply constraints
Reuters via Yahoo News· 1 year agoCOPENHAGEN (Reuters) -Danish drug developer Novo Nordisk on Wednesday presented "strong" sales...
Billionaire Investor Jim Simons Just Bought These 3 "Magnificent Seven" Stocks
Motley Fool via Yahoo Finance· 4 days agoA good way to spot trends in the stock market is to look at which companies asset management firms...
Novo Nordisk Stock Outlook: Popular Prescriptions Seal the Deal
InvestorPlace via Yahoo Finance· 9 months agoMaybe you’re not very familiar with Danish drugmaker Novo Nordisk (NYSE:NVO) stock. However, there’s a good chance that you’ve heard about at least one of Novo Nordisk’s well-known products.